Skip to main content

Another Exciting Could Lift Long-Term Genomics Outlook

Among ETFs focusing on disruptive themes, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is rarely short of compelling catalysts. ARKG includes companies that merge healthcare with technology and capitalize on the revolution in genomic sequencing. These companies try to better understand...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.